PharmaTimesNews & Politicsnews

Anocca doses first patients with precision TCR‑T therapy

Thursday, June 11, 2026John PinchingView original

Company begins phase 1 treatment in multi‑centre VIDAR‑1 trial

Read the full article on the original site.

Read Full Article